Medicare Administration Announces Significant Price Reductions for Ten Widely Prescribed Pharmaceutical Drugs
Federal healthcare officials successfully negotiated price reductions of up to sixty percent on highly utilized medications treating diabetes, heart disease, and blood clots, projecting billions of United States dollars in out-of-pocket savings for elderly patients enrolled in the federal Medicare program.